                               SEQUENCE LISTING	

<110> NEVADA CANCER INSTITUTE
      SHENZHEN GRADUATE SCHOOL OF PEKING UNIVERSITY
 
<120> HISTONE DEMETHYLASE INHIBITORS AND USES THEREOF FOR TREATMENT OF 
      CANCER

<130> 089393-0013

<140>
<141>

<150> 61/416,566
<151> 2010-11-23

<160> 15    

<170> PatentIn version 3.5

<210> 1
<211> 23
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 1
cactacttcc tacttcaatg gca                                               23


<210> 2
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 2
cagcgataag aaggcccag                                                    19


<210> 3
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 3
tcacacctgt caatggcagc                                                   20


<210> 4
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 4
gccagtagcc cttgatgatg                                                   20


<210> 5
<211> 23
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 5
tccagccttc cttcttgggt atg                                               23


<210> 6
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 6
gaaggtggac agtgaggcca ggat                                              24


<210> 7
<211> 19
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 7
aaggaaagcu agaagaaaa                                                    19


<210> 8
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 8
ccatccgact ggagcagcta                                                   20


<210> 9
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 9
gctcatgtat gtgttcatgc cattc                                             25


<210> 10
<211> 21
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 10
gagccgagau ggucauaaau u                                                 21


<210> 11
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 11
cagaggataa ccttgttta                                                    19


<210> 12
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 12
cgtacgcgga atacttcga                                                    19


<210> 13
<211> 21
<212> PRT
<213> Homo sapiens

<400> 13
Ala Arg Thr Lys Gln Thr Ala Arg Lys Ser Thr Gly Gly Lys Ala Pro 
1               5                   10                  15      


Arg Lys Gln Leu Ala 
            20      


<210> 14
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Ala Arg Thr Met Gln Thr Ala Arg Lys Ser Thr Gly Gly Lys Ala Pro 
1               5                   10                  15      


Arg Lys Gln Leu Ala 
            20      


<210> 15
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 15
aaacagcgat aagaaggccc ag                                                22


